Crosstalk between the lncRNA UCA1 and microRNAs in cancer

被引:35
|
作者
Xuan, Wei [1 ]
Yu, Hongyu [2 ]
Zhang, Xiaoling [3 ,4 ]
Song, Dandan [5 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Hepatopancreaticobiliary Surg, Changchun, Jilin, Peoples R China
[2] Jilin Univ, Hosp 2, Dept Nephrol, Changchun, Jilin, Peoples R China
[3] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China
[4] Jilin Univ, Inst Immunol, Changchun, Jilin, Peoples R China
[5] Jilin Univ, Hosp 2, Dept Clin Lab, 218 Zigiang St, Changchun 130041, Jilin, Peoples R China
关键词
cancer; drug resistance; invasion; metabolism; micro RNA; proliferation; UCA1; LONG NONCODING RNA; COMPETING ENDOGENOUS RNA; RENAL-CELL CARCINOMA; ENHANCES TAMOXIFEN RESISTANCE; PAPILLARY THYROID-CARCINOMA; PREDICTS POOR-PROGNOSIS; BLADDER-CANCER; LUNG-CANCER; PROMOTES PROLIFERATION; CISPLATIN RESISTANCE;
D O I
10.1002/1873-3468.13470
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long non-coding RNAs (lncRNAs) are a major subset of highly conserved non-coding RNAs (ncRNAs) that consist of at least 200 nucleotides and have limited protein-coding potential. Cumulative data have shown that lncRNAs are deregulated in many types of cancer and may control pathophysiological processes of cancer at various levels, including transcription, post-transcription and translation. Recently, lncRNAs have been demonstrated to interact with microRNAs (miRNAs), another major subset of ncRNAs, which regulate physiological and pathological processes by inhibiting target mRNA translation or promoting mRNA degradation. The lncRNA urothelial carcinoma-associated 1 (UCA1) has recently gained much attention as it is overexpressed in many types of cancer and is involved in carcinogenesis. Here, we review the crosstalk between UCA1 and miRNAs during the pathogenesis of cancer, with a focus on cancer-cell proliferation, invasion, drug resistance, and metabolism.
引用
收藏
页码:1901 / 1914
页数:14
相关论文
共 50 条
  • [21] Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis
    Li, Wei
    Xie, Peng
    Ruan, Wen-hui
    JOURNAL OF BONE ONCOLOGY, 2016, 5 (02) : 80 - 85
  • [22] LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival
    Wan, Yanhui
    Yao, Da
    Fang, Fuyuan
    Wang, Youyu
    Wu, Guodong
    Qian, Youhui
    BMC CANCER, 2021, 21 (01)
  • [23] lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion
    Zha, Zhuqing
    Han, Qingmin
    Liu, Wenjing
    Huo, Shaochuan
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2020, 15 (01)
  • [24] LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival
    Yanhui Wan
    Da Yao
    Fuyuan Fang
    Youyu Wang
    Guodong Wu
    Youhui Qian
    BMC Cancer, 21
  • [25] Is there a place for the UCA1 test in bladder cancer detection?
    Milowich, D.
    Le Mercier, M.
    De Neve, N.
    Fossion, C.
    Sandras, F.
    Roumeguere, T.
    Decaestecker, C.
    Salmon, I.
    Rorive, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S202 - S202
  • [26] Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer
    Wang, Minghui
    Zhang, Zhijun
    Pan, Deng
    Xin, Zhigang
    Bu, Fan
    Zhang, Yue
    Tian, Qingwu
    Feng, Xiaodong
    BIOSCIENCE REPORTS, 2021, 41 (07)
  • [27] Serum-Based lncRNA ANRIL, TUG1, UCA1, and HIT Expressions in Breast Cancer Patients
    Alkhathami, Ali G.
    Hadi, Abdul
    Alfaifi, Mohammed
    Alshahrani, Mohammad Yahya
    Verma, Amit Kumar
    Beg, Mirza Masroor Ali
    DISEASE MARKERS, 2022, 2022
  • [28] Lncrna uca1 interacts directly with angiomotin to activate Hippo-YAP signaling in epithelial ovarian cancer
    Lin, Xianzhi
    Spindler, Tassja J.
    Gayther, Simon A.
    Lawrenson, Kate
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Up-regulation of LncRNA UCA1 by TGF-β promotes doxorubicin resistance in breast cancer cells
    Wo, Like
    Zhang, Bei
    You, Xiongbin
    Hu, Yuanyuan
    Gu, Zhenqi
    Zhang, Mengning
    Wang, Qi
    Lv, Zhengyi
    Zhao, Hong
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2022, 44 (04) : 492 - 499
  • [30] LncRNA UCA1在肿瘤诊断中的研究进展
    王思宇
    王宇
    生命科学, 2022, 34 (07) : 806 - 814